Tag Archives: designer drugs
Estimating effects of new psychoactive substances (NPS) based on in vitro neurotoxicity data
The use of new psychoactive substances (NPS) is increasing and currently > 600 NPS have been reported. However, limited information on neuropharmacological and toxicological effects of NPS is available, hampering risk characterization. We reviewed the literature on
New psychoactive substances and drugs of abuse inhibit the reuptake of monoamines via monoamine transporters
The use of illicit drugs is high and 5% of the population worldwide used an illicit drug in the last year. While the prevalence of use of these common drugs is decreasing, the use of new psychoactive
New psychoactive substances and drugs of abuse inhibit neuronal activity
New psychoactive substances (NPS), also known as ‘legal highs’, ‘bath salts’ or ‘research chemicals’, appeared on the drug market around a decade ago. Even though they account for only a small proportion of the market, NPS encompass
